|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zeng H, Zheng R, Zhang S, Zuo T, Xia C,
Zou X and Chen W: Esophageal cancer statistics in China, 2011:
Estimates based on 177 cancer registries. Thorac Cancer. 7:232–237.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Howlader N, Noone AM, Krapcho M, Garshell
J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,
et al: SEER Cancer Statistics Review, 1975–20112014; National
Cancer Institute. Bethesda, MD: http://seer.cancer.gov/csr/1975_2011/based on
November 2013 SEER data submission, posted to the SEER web site.
April. 2014 View Article : Google Scholar
|
|
4
|
Barbour AP, Jones M, Brown I, Gotley DC,
Martin I, Thomas J, Clouston A and Smithers BM: Risk stratification
for early esophageal adenocarcinoma: Analysis of lymphatic spread
and prognostic factors. Ann Surg Oncol. 17:2494–2502. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ajani JA, D'Amico TA, Almhanna K, Bentrem
DJ, Besh S, Chao J, Das P, Denlinger C, Fanta P, Fuchs CS, et al:
Esophageal and esophagogastric junction cancers, version 1.2015. J
Nati Compr Canc Netw. 13:194–227. 2015. View Article : Google Scholar
|
|
6
|
Zuccaro G Jr, Rice TW, Goldblum J,
Medendorp SV, Becker M, Pimentel R, Gitlin L and Adelstein DJ:
Endoscopic ultrasound cannot determine suitability for
esophagectomy after aggressive chemoradiotherapy for esophageal
cancer. Am J Gastroenterol. 94:906–912. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tomizawa Y and Wang KK: Screening,
surveillance, and prevention for esophageal cancer. Gastroenterol
Clin North Am. 38(59–73): viii2009.
|
|
8
|
Kato H, Kuwano H, Nakajima M, Miyazaki T,
Yoshikawa M, Ojima H, Tsukada K, Oriuchi N, Inoue T and Endo K:
Comparison between positron emission tomography and computed
tomography in the use of the assessment of esophageal carcinoma.
Cancer. 94:921–928. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sakai NS, Samia-Aly E, Barbera M and
Fitzgerald RC: A review of the current understanding and clinical
utility of miRNAs in esophageal cancer. Semin Cancer Biol.
23:512–521. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kozomara A and Griffiths-Jones S: miRBase:
Annotating high confidence microRNAs using deep sequencing data.
Nucleic Acids Res. 42:(Database Issue). D68–D73. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets
and gene nomenclature. Nucleic Acids Res. 34:(Database Issue).
D140–D144. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kroh EM, Parkin RK, Mitchell PS and Tewari
M: Analysis of circulating microRNA biomarkers in plasma and serum
using quantitative reverse transcription-PCR (qRT-PCR). Methods.
50:298–301. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ali S, Almhanna K, Chen W, Philip PA and
Sarkar FH: Differentially expressed miRNAs in the plasma may
provide a molecular signature for aggressive pancreatic cancer. Am
J Transl Res. 3:28–47. 2010.PubMed/NCBI
|
|
20
|
Wang B and Zhang Q: The expression and
clinical significance of circulating microRNA-21 in serum of five
solid tumors. J Cancer Res Clin Oncol. 138:1659–1666. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fassan M, Baffa R, Kiss A, Zaninotto G and
Rugge M: MicroRNA dysregulation in esophageal neoplasia: The
biological rationale for novel therapeutic options. Curr Pharm Des.
19:1236–1241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Redova M, Sana J and Slaby O: Circulating
miRNAs as new blood-based biomarkers for solid cancers. Future
Oncol. 9:387–402. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu SG, Qin XG, Zhao BS, Qi B, Yao WJ,
Wang TY, Li HC and Wu XN: Differential expression of miRNAs in
esophageal cancer tissue. Oncol Lett. 5:1639–1642. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gilson PR and McFadden GI: The
miniaturized nuclear genome of a eukaryotic endosymbiont contains
genes that overlap, genes that are cotranscribed, and the smallest
known spliceosomal introns. Proc Natl Acad Sci USA. 93:7737–7742.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schmittgen TD, Jiang J, Liu Q and Yang L:
A high-throughput method to monitor the expression of microRNA
precursors. Nucleic Acids Res. 32:e432004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
MacCallum RC, Zhang S, Preacher KJ and
Rucker DD: On the practice of dichotomization of quantitative
variables. Psychol Methods. 7:19–40. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hand DJ and Till RJ: A simple
generalisation of the area under the ROC curve for multiple class
classification problems. Mach Learn. 45:171–186. 2001. View Article : Google Scholar
|
|
32
|
Schisterman EF, Perkins NJ, Liu A and
Bondell H: Optimal cut-point and its corresponding Youden Index to
discriminate individuals using pooled blood samples. Epidemiology.
16:73–81. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Akobeng AK: Understanding diagnostic tests
3: Receiver operating characteristic curves. Acta Paediatr.
96:644–647. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang LH, Wang SL, Tang LL, Liu B, Ye WL,
Wang LL, Wang ZY, Zhou MT and Chen BC: Universal stem-loop primer
method for screening and quantification of microRNA. PLoS One.
9:e1152932014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schmittgen TD, Zakrajsek BA, Mills AG,
Gorn V, Singer MJ and Reed MW: Quantitative reverse
transcription-polymerase chain reaction to study mRNA decay:
Comparison of endpoint and real-time methods. Anal Biochem.
285:194–204. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yin JL, Shackel NA, Zekry A, McGuinness
PH, Richards C, Putten KV, McCaughan GW, Eris JM and Bishop GA:
Real-time reverse transcriptase-polymerase chain reaction (RT-PCR)
for measurement of cytokine and growth factor mRNA expression with
fluorogenic probes or SYBR Green I. Immunol Cell Biol. 79:213–221.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol
Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kuhn AR, Schlauch K, Lao R, Halayko AJ,
Gerthoffer WT and Singer CA: MicroRNA expression in human airway
smooth muscle cells: Role of miR-25 in regulation of airway smooth
muscle phenotype. Am J Respir Cell Mol Biol. 42:506–513. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang H, Zuo Z, Lu X, Wang L, Wang H and
Zhu Z: MiR-25 regulates apoptosis by targeting Bim in human ovarian
cancer. Oncol Rep. 27:594–598. 2012.PubMed/NCBI
|
|
43
|
Liu R, Liao J, Yang M, Sheng J, Yang H,
Wang Y, Pan E, Guo W, Pu Y, Kim SJ and Yin L: The cluster of
miR-143 and miR-145 affects the risk for esophageal squamous cell
carcinoma through co-regulating fascin homolog 1. PLoS One.
7:e339872012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Furuta M, Kozaki KI, Tanaka S, Arii S,
Imoto I and Inazawa J: miR-124 and miR-203 are epigenetically
silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Carcinogenesis. 31:766–776. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yuan Y, Zeng ZY, Liu XH, Gong DJ, Tao J,
Cheng HZ and Huang SD: MicroRNA-203 inhibits cell proliferation by
repressing ΔNp63 expression in human esophageal squamous cell
carcinoma. BMC Cancer. 11:572011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Engell HC: CCancer cells in the
circulating blood; a clinical study on the occurrence of cancer
cells in the peripheral blood and in venous blood draining the
tumour area at operation. Acta Chir Scand Suppl. 201:1–70.
1955.PubMed/NCBI
|
|
47
|
Okumura Y, Tanaka F, Yoneda K, Hashimoto
M, Takuwa T, Kondo N and Hasegawa S: Circulating tumor cells in
pulmonary venous blood of primary lung cancer patients. Ann Thorac
Surg. 87:1669–1675. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LW and Hayes DF: Circulating tumor cells, disease
progression, and survival in metastatic breast cancer. N Engl J
Med. 351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhuang LP and Meng ZQ: Serum miR-224
reflects stage of hepatocellular carcinoma and predicts survival.
Biomed Res Int. 2015:7317812015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Agrawal N, Jiao Y, Bettegowda C, Hutfless
SM, Wang Y, David S, Cheng Y, Twaddell WS, Latt NL, Shin EJ, et al:
Comparative genomic analysis of esophageal adenocarcinoma and
squamous cell carcinoma. Cancer Discov. 2:899–905. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Barbash S, Shifman S and Soreq H: Global
coevolution of human microRNAs and their target genes. Mol Biol
Evol. 31:1237–1247. 2014. View Article : Google Scholar : PubMed/NCBI
|
